Estados Unidos · Plataformas y datos · Yahoo Finance

Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors

Publicado por Yahoo Finance · Estados Unidos hace 9 h

Mr. Astley-Sparke brings more than two decades of biotech leadership, having scaled several highly innovative transatlantic companies, including Replimune, uniQure and BioVex --…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors

También te puede interesar

DNOW Inc. (NYSE:DNOW) Stock Rated "Moderate Buy" by Sell-Side Brokerages

It’s a rough housing market, and Goldman Sachs expects it to get worse

President Donald Trump Claims, "We Don't Have Inflation, and Tariffs Don't Cause Inflation," but a New Report Strongly Disagrees

U.S. to allow 'dark fleet' tankers to ship oil legally

France imposes curfews in parts of Paris, other cities after weekend of riots

The world’s finance chiefs see new risks — and less China angst

Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors

Compartir

También te puede interesar

DNOW Inc. (NYSE:DNOW) Stock Rated "Moderate Buy" by Sell-Side Brokerages

It’s a rough housing market, and Goldman Sachs expects it to get worse

President Donald Trump Claims, "We Don't Have Inflation, and Tariffs Don't Cause Inflation," but a New Report Strongly Disagrees

U.S. to allow 'dark fleet' tankers to ship oil legally

France imposes curfews in parts of Paris, other cities after weekend of riots

The world’s finance chiefs see new risks — and less China angst